Codexis Inc (CDXS)
3.485
-0.04
(-1.27%)
USD |
NASDAQ |
Mar 28, 16:00
3.485
0.00 (0.00%)
After-Hours: 16:48
Codexis Enterprise Value: 183.06M for March 27, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
March 27, 2024 | 183.06M |
March 26, 2024 | 177.43M |
March 25, 2024 | 177.43M |
March 22, 2024 | 177.43M |
March 21, 2024 | 180.24M |
March 20, 2024 | 180.24M |
March 19, 2024 | 164.78M |
March 18, 2024 | 163.37M |
March 15, 2024 | 169.00M |
March 14, 2024 | 159.86M |
March 13, 2024 | 172.51M |
March 12, 2024 | 178.84M |
March 11, 2024 | 188.68M |
March 08, 2024 | 178.84M |
March 07, 2024 | 192.20M |
March 06, 2024 | 190.79M |
March 05, 2024 | 199.23M |
March 04, 2024 | 230.51M |
March 01, 2024 | 258.98M |
February 29, 2024 | 261.80M |
February 28, 2024 | 196.41M |
February 27, 2024 | 226.64M |
February 26, 2024 | 159.86M |
February 23, 2024 | 147.90M |
February 22, 2024 | 135.51M |
Date | Value |
---|---|
February 21, 2024 | 134.11M |
February 20, 2024 | 136.91M |
February 16, 2024 | 157.18M |
February 15, 2024 | 161.38M |
February 14, 2024 | 132.02M |
February 13, 2024 | 124.68M |
February 12, 2024 | 152.99M |
February 09, 2024 | 144.60M |
February 08, 2024 | 139.01M |
February 07, 2024 | 129.22M |
February 06, 2024 | 135.51M |
February 05, 2024 | 115.94M |
February 02, 2024 | 125.03M |
February 01, 2024 | 127.82M |
January 31, 2024 | 118.73M |
January 30, 2024 | 129.22M |
January 29, 2024 | 134.11M |
January 26, 2024 | 129.22M |
January 25, 2024 | 121.53M |
January 24, 2024 | 123.28M |
January 23, 2024 | 143.90M |
January 22, 2024 | 131.32M |
January 19, 2024 | 122.93M |
January 18, 2024 | 122.23M |
January 17, 2024 | 122.23M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
12.61M
Minimum
Sep 25 2023
2.591B
Maximum
Nov 08 2021
743.06M
Average
692.27M
Median
Enterprise Value Benchmarks
Ampio Pharmaceuticals Inc | -5.467M |
Sutro Biopharma Inc | -71.06M |
Avidity Biosciences Inc | 1.374B |
Taysha Gene Therapies Inc | 489.42M |
Janux Therapeutics Inc | 1.618B |
Enterprise Value Related Metrics
Net Income (Quarterly) | -7.192M |
Revenue (Quarterly) | 26.56M |
Total Expenses (Quarterly) | 26.28M |
EPS Diluted (Quarterly) | -0.10 |
Gross Profit Margin (Quarterly) | 89.22% |
Profit Margin (Quarterly) | -27.08% |
Earnings Yield | -31.85% |
Normalized Earnings Yield | -27.52 |